Skip to main navigation
ZyVersa Therapeutics, Inc. logo
  • Overview
  • News & Events
    • News Releases
    • Events
    • ZyVersa in the News
    • Media Resources
  • Financials & Filings
    • Overview
    • All SEC Filings
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board of Directors
    • Committee Composition
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Investor Resources
    • Investor FAQs
    • Presentations
    • Email Alerts
    • Contact IR

ZyVersa in the News

ZyVersa in the News

New Research Finds Antibody Detects Alzheimer’s Signals at Earliest Stages
March 14, 2023
Meet ZyVersa: Fly Exclusive Interview with CEO Stephen Glover
January 12, 2023
Changing Lives Through the Power of Technology
February 1, 2020
Kidney is the new liver: why kidney indications are coming into sharp focus
October 3, 2019
Developing Innovative Drug Therapies for Patients with Inflammatory and Renal Diseases
September 23, 2019
Biotechs explore the next generation of inflammasome targets, with caution
August 15, 2019
Print Page
Email Alerts
Contact IR
ZyVersa Therapeutics, Inc. logo
  • About
  • Inflammasomes
  • Renal Lipids
  • Pipeline
  • Careers
  • Investors & Media
  • Contact
  • ©2023 ZyVersa Therapeutics, Inc. All rights reserved.
  • Privacy Policy
  • Disclaimer
  • Trademarks
  • Sitemap